← SynDRA
VALBENAZINE
SynDRA canonical compound SYN0037201 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | SLC18A2 |
|---|
| Mechanism of action | vesicular monoamine transporter inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- SLC18A2 INHIBITOR
- Synaptic vesicular amine transporter inhibitor
- vesicular monoamine transporter inhibitor
- SLC18A2 ANTAGONIST
- SLC18A2 MODULATOR
Drug classes
- Vesicular Monoamine Transporter 2 Inhibitors
- Vesicular Monoamine Transporter 2 Inhibitor
ATC classes
- N07X · OTHER NERVOUS SYSTEM DRUGS
Cross-references
Synonyms
- valbenazine tosylate
- ingrezza
- NBI 98854
- valbenazine ditosylate
- dysval
- Valbenazina
- Mt-5199
- NBI-98854
- NBI-98782
- Vesicular monoamine transporter 2 inhibitor (CNS indications), Neurocrine
- VMAT-2 inhibitor (CNS disease), Neurocrine
- Valbenazine Tosylate
- Valbenazine ditosylate
- UNII-5SML1T733B
- 5SML1T733B
- Valbenazine tosylate [USAN]
- Valbenazine tosylate (USAN)
- NBI-98854 ditosylate
- Ingrezza
- UNII-54K37P50KH
- Valbenazine free base
- 54K37P50KH
- 1025504-45-3 (free base)
- (2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-yl L-valinate
- L-Valine, (2R,3R,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-yl ester
- Valbenazine [USAN:INN]
- L-Valine, (2R,3R,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo(a)quinolizin-2-yl ester
- ValbenazineNBI-98854
- Valbenazine (USAN/INN)
- GTPL8694
- CHEMBL2364639
- SCHEMBL15932979
- EX-A2002
- MFCD28963976
- ZINC43195697
- CS-5908
- DB11915
- SB17456
Look up VALBENAZINE in the interactive SynDRA portal →